Propagation, infection, and neutralization of authentic HPV16 virus

Virology

Volumn 322, Issue 2, 2004, Pages 213-219

  McLaughlin Drubin, Margaret E ^a   Christensen, Neil D ^a,b   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Differentiation; HPV16; Keratinocytes

Indexed keywords

GENOMIC DNA; MONOCLONAL ANTIBODY;

ARTICLE; EPISOME; HUMAN; HUMAN CELL; KERATINOCYTE; LABORATORY; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; STRATIFICATION; VIRION; VIRUS INFECTION; VIRUS NEUTRALIZATION; WART VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, VIRAL; HUMANS; KERATINOCYTES; NEUTRALIZATION TESTS; ORGAN CULTURE TECHNIQUES; PAPILLOMAVIRIDAE; RATS; VIRUS CULTIVATION; VIRUS REPLICATION;

PAPILLOMAVIRUS;

EID: 1942489261     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.02.011     Document Type: Article

References (26)

1. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87(11):1995;796-802.
2. Bromberg-White J.L., Meyers C. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology. 306(2):2003;197-202.
3. Brune W., Dürst M. Epithelial differentiation fails to support replication of cloned human papillomavirus type 16 DNA in transfected keratinocytes. J. Invest. Dermatol. 104(2):1995;277-281.
4. Christensen N.D., Reed C.A., Cladel N.M., Hall K., Leiserowitz G.S. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology. 224(2):1996;477-486.
5. Christensen N.D., Cladel N.M., Reed C.A., Budgeon L.R., Embers M.E., Skulsky D.M., McClements W.L., Ludmerer S.W., Jansen K.U. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology. 291(2):2001;324-334.
6. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer. 89(1):2003;101-105.
7. Flores E.R., Allen-Hoffmann B.L., Lee D., Sattler C.A., Lambert P.F. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology. 262(2):1999;344-354.
8. Hubert W.G., Laimins L.A. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression. J. Virol. 76(5):2002;2263-2273.
9. Kirnbauer R., Taub J., Greenstone H., Roden R., Durst M., Gissmann L., Lowy D.R., Schiller J.T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67(12):1993;6929-6936.
10. Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kuypers J.M., Koutsky L.A. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 288(14):2002;1749-1757.
11. Lorincz A.T., Reid R., Jenson A.B., Greenberg M.D., Lancaster W., Kurman R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79(3):1992;328-337.
12. McLaughlin-Drubin M.E., Wilson S., Mullikin B., Suzich J., Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology. 312(1):2003;1-7.
13. Meyers C., Frattini M.G., Hudson J.B., Laimins L.A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 257(5072):1992;971-973.
14. Meyers C., Mayer T.J., Ozbun M.A. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71(10):1997;7381-7386.
15. Meyers C., Bromberg-White J.L., Zhang J., Kaupas M.E., Bryan J.T., Lowe R.S., Jansen K.U. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J. Virol. 76(10):2002;4723-4733.
16. Mohar A., Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest. 18(6):2000;584-590.
17. Ozbun M.A., Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71(7):1997;5161-5172.
18. Ozbun M.A., Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology. 248(2):1998;218-230.
19. Parkin, D.M., Pisani, P., Ferlay, J., 1999. Global cancer statistics. CA Cancer J. Clin. 49 (1), 33-64, 1.
20. Roden R.B., Greenstone H.L., Kirnbauer R., Booy F.P., Jessie J., Lowy D.R., Schiller J.T. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70(9):1996;5875-5883.
21. Roden R.B., Armstrong A., Haderer P., Christensen N.D., Hubbert N.L., Lowy D.R., Schiller J.T., Kirnbauer R. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope. J. Virol. 71(8):1997;6247-6252.
22. Sen E., Bromberg-White J.L., Meyers C. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 76(10):2002;4798-4809.
23. Smith L.H., Foster C., Hitchcock M.E., Leiserowitz G.S., Hall K., Isseroff R., Christensen N.D., Kreider J.W. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J. Invest. Dermatol. 105(3):1995;438-444.
24. Stanley M.A., Browne H.M., Appleby M., Minson A.C. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer. 43(4):1989;672-676.
25. White W.I., Wilson S.D., Bonnez W., Rose R.C., Koenig S., Suzich J.A. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J. Virol. 72(2):1998;959-964.
26. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184(1):1991;9-13.